ENFORTUMAB VEDOTIN-EJFV | B761137 | ASTELLAS
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Dec. 18, 2031 | Active | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12419964(composition) · relevance 90/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 71 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.